Why is Dr Agarwals Eye Hospital Ltd falling/rising?

Recent Price Movement and Market Context

The stock has underperformed relative to the broader market and its sector peers in recent sessions. Over the past week, the share price has fallen by 4.53%, significantly more than the Sensex’s 1.83% decline. This negative trend extends over the last month, with the stock dropping 9.47%, compared to a modest 1.63% fall in the benchmark index. Year-to-date, the stock is down 5.97%, again lagging the Sensex’s 1.58% decline. Notably, the stock has been on a three-day losing streak, shedding 5.11% during this period, signalling sustained selling pressure.

Intraday trading on 12-Jan saw the stock touch a low of ₹4,952, a 2.87% drop from previous levels, with heavier volumes traded near this lower price point. This suggests that sellers dominated the session, pushing prices down despite the stock’s liquidity remaining adequate for moderate trade sizes. The weighted average price also indicates that more shares exchanged hands closer to the day’s lows, reinforcing the bearish sentiment.

Technically, the stock remains above its 200-day moving average, a long-term support indicator, but is trading below its 5-day, 20-day, 50-day, and 100-day moving averages. This pattern often signals short- to medium-term weakness, as recent price action fails to sustain levels above these key averages, which can influence investor sentiment negatively.

Fundamental Performance and Valuation

Despite the recent price weakness, Dr Agarwals Eye Hospital Ltd continues to demonstrate robust operational growth. The company has reported positive results for three consecutive quarters, with quarterly net sales reaching a high of ₹117.72 crores and PBDIT peaking at ₹40.08 crores. Operating cash flow for the year stands at a strong ₹94.48 crores, underscoring healthy cash generation capabilities.

Operating profit has grown at an impressive annual rate of 118.82%, reflecting the company’s ability to expand its earnings base effectively. Return on capital employed (ROCE) is a respectable 16.6%, indicating efficient use of capital to generate profits. The enterprise value to capital employed ratio of 4.8 suggests a fair valuation, with the stock currently trading at a discount relative to its peers’ historical averages.

However, the stock’s one-year return of -26.23% contrasts sharply with the Sensex’s positive 8.40% gain over the same period. This divergence suggests that despite improving profitability—profits have risen by 24.7% in the past year—the market has not rewarded the stock accordingly. The company’s PEG ratio of 1.8 indicates that the stock’s price may not fully reflect its earnings growth potential, but investor caution remains evident.

Investor Sentiment and Trading Activity

Investor participation has shown signs of increasing, with delivery volumes on 9 Jan rising by 89.07% compared to the five-day average. This heightened activity could reflect a mix of profit-taking and repositioning by market participants amid the recent price declines. The stock’s liquidity remains sufficient for trades of approximately ₹0.02 crores, ensuring that investors can enter or exit positions without significant market impact.

In summary, the recent decline in Dr Agarwals Eye Hospital Ltd’s share price appears to be driven by short-term market pressures and technical factors rather than fundamental weaknesses. While the company continues to deliver strong operational results and maintains a fair valuation, the stock’s underperformance relative to the broader market and sector peers has weighed on investor sentiment. The combination of recent consecutive losses, trading below key moving averages, and increased selling near intraday lows has contributed to the current downward trend.

Investors should weigh the company’s solid long-term growth prospects and improving profitability against the prevailing market dynamics and valuation considerations when making investment decisions.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →